Sign In
Buy SNN
$29.36
-0.120 (-0.407%)
At Close: Jun 02, 2026
Smith & Nephew says 'on track' to meet full-year revenue forecast
03:56am, Thursday, 03'rd Nov 2022
Smith & Nephew PLC (LSE:SN) reported a 4.8% increase in underlying revenue for the third quarter and forecast revenue growth for the full year in the middle of its previously guided range of 4%-5%.
Smith & Nephew little boosted by rivals' reports of improving hip and knee sales
04:20am, Friday, 21'st Oct 2022
Smith & Nephew PLC (LSE:SN) shares reacted to reports from US medical technology companies that surgical procedure volumes are returning to pre-pandemic levels.
Smith & Nephew: Still A Buy Despite Short-Term Challenges
08:21am, Monday, 26'th Sep 2022
Medical devices manufacturer Smith & Nephew (S&N) has seen its shares sliding. I do not yet see the growth the company is targeting, but business has been recovering and its interim figures were decen
Smith & Nephew: A Medical Equipment Opportunity
04:54pm, Tuesday, 09'th Aug 2022
FTSE 100 constituent and medical equipment maker Smith & Nephew PLC ( SNN , Financial) ( LSE:SN. , Financial) seemed to be making progress after its 2021 results in February.
Smith & Nephew plc (SNN) CEO Deepak Nath on Q2 2022 Results - Earnings Call Transcript
06:04pm, Friday, 29'th Jul 2022
Smith & Nephew plc (NYSE:SNN ) Q2 2022 Results Conference Call July 28, 2022 3:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Confe
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
09:55am, Friday, 29'th Jul 2022 Benzinga
Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 20
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
04:41pm, Thursday, 28'th Jul 2022 Benzinga
Gainers
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 231% to $2.63 on news that the company will be acquired By Henry Crown and Company for $3.25 per share. Petros Pharmaceuticals, however, con
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
03:45pm, Thursday, 28'th Jul 2022 Benzinga
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan.
Pathward Financial, Inc. (NASDAQ: CASH) fell 25.2% to $32.26
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket
10:09am, Thursday, 28'th Jul 2022 Benzinga
Gainers
JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 34.7% to $23.01 in pre-market trading after the company reported better-than-expected Q2 results.
Athersys, Inc. (NASDAQ: ATHX) rose 35.1% to $0.2568 i
Smith & Nephew's shares slump as profit margins squeezed
05:35am, Thursday, 28'th Jul 2022
Shares in Smith & Nephew PLC (LSE:SN) plunged almost 10% after forecasting a drop in profit margins on the back of inflation and “external supply challenges". The British medical products maker no
Oxford Biomedica, Smith & Nephew 'vulnerable' to takeover
05:22am, Tuesday, 07'th Jun 2022
Oxford BioMedica PLC (AIM:OXB), Smith & Nephew PLC (LSE:SN) and Spire Healthcare Group Plc (LSE:SPI) are among UK midcap health-care companies 'vulnerable” to takeovers from private-equity (PE) fir
Smith & Nephew: Fair Price For An Attractive Medical Devices Supplier
01:33am, Wednesday, 01'st Jun 2022
Smith & Nephew has seen its business performance turn the corner post-pandemic and I expect future growth. The share price has crept up slightly but I continue to see long-term value here.
Smith & Nephew Posts Q1 Sales Growth As Elective Procedures Rebound
03:27pm, Thursday, 28'th Apr 2022
Smith & Nephew PLC (NYSE: SNN) posted Q1 revenue of $1.31 billion, up 3.3% on a reported basis (including -2.6% currency effect) and up 5.9% on an underlying basis. Sports Medicine & ENT revenue up
Smith & Nephew revenues jump as elective procedure volumes rebound
06:45am, Thursday, 28'th Apr 2022
Smith & Nephew PLC (LSE:SN) (Smith & Nephew PLC (LSE:SN)) said a recovery in elective surgery and good sports demand would keep it on track to hit its targets in 2022. Revenue in the first quarter ro
Smith & Nephew initiated at outperform at RBC on revenue growth and margins (NYSE:SNN)
02:14pm, Wednesday, 16'th Mar 2022 Seeking Alpha
RBC Capital Markets has initiated Smith & Nephew (SNN) with an outperform rating, citing the medical device companys potential acceleration in revenue growth and margins.
